Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease - Archive ouverte HAL Access content directly
Journal Articles Molecular Vision Year : 2020

Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease

(1, 2) , (1) , (3, 4) , (1, 5)
1
2
3
4
5

Abstract

Bile acids are produced in the liver and excreted into the intestine, where their main function is to participate in lipid digestion. Ursodeoxycholic acid (UDCA) and tauroursodeoxycholic acid (TUDCA) have shown antiapoptotic, anti-inflammatory, and antioxidant effects in various models of neurodegenerative diseases. However, little is known about signaling pathways and molecular mechanisms through which these bile acids act as neuroprotectors, delaying translation to the clinical setting. We review evidence supporting a potentially therapeutic role for bile acids in retinal disorders, and the mechanisms and pathways involved in the cytoprotective effects of bile acids from the liver and the enterohepatic circulation to the central nervous system and the retina. As secondary bile acids are generated by the microbiota metabolism, bile acids might be a link between neurodegenerative retinal diseases and microbiota.

Dates and versions

inserm-02980558 , version 1 (27-10-2020)

Identifiers

Cite

Alejandra Daruich, Émilie Picard, Jeffrey Boatright, Francine Behar-Cohen. Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease. Molecular Vision, 2020, 25, pp.610-624. ⟨inserm-02980558⟩
21 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More